| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 240 | $27.02 | $6,484.80 | -0.4% | -19.5% | -3.3% | |
| Jan 6, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 343 | $27.02 | $9,267.86 | -0.3% | -19.5% | -3.3% | |
| Jan 6, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 18,411 | $0.78 | $14,270.37 | +0.1% | -8.8% | +2.1% | |
| Jan 6, 2025 | SERA Sera Prognostics, Inc. | Mirza Mansoor Raza79 | Director | Sell | 100 | $7.69 | $769.00 | -1.5% | -56.0% | -61.6% | |
| Jan 6, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 987 | $27.02 | $26,668.74 | -0.8% | -19.5% | -3.3% | |
| Jan 3, 2025 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 167 | $241.28 | $40,293.76 | -1.9% | +12.9% | +27.9% | |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | Bauerlein Alison73 | Chief Financial Officer | Sell | 10,102 | $3.52 | $35,579.24 | -2.6% | -36.1% | +114.3% | |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | Badawi David59 | Chief Technology Officer | Sell | 3,111 | $3.52 | $10,956.94 | -0.2% | -36.1% | +114.3% | |
| Jan 3, 2025 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 4,864 | $3.52 | $17,131.01 | -3.1% | -36.1% | +114.3% | |
| Jan 3, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 375,000 | $25.17 | $9,437,514.92 | -91.0% | -39.1% | -14.5% | |
| Jan 3, 2025 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 7,152 | $89.86 | $642,657.98 | -20.1% | +8.6% | +4.4% | |
| Jan 3, 2025 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 9,689 | $89.86 | $870,636.10 | -4.1% | +8.6% | +4.4% | |
| Jan 3, 2025 | BSX Boston Scientific Corp | Sorenson John Bradley55 | EVP, Global Operations | Sell | 6,461 | $89.96 | $581,241.46 | -8.6% | +8.6% | +4.4% | |
| Jan 2, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,302 | $0.68 | $3,615.96 | - | -2.0% | +3.5% | |
| Jan 2, 2025 | PEN Penumbra Inc | Kassing Don W.49 | Director | Sell | 170 | $238.84 | $40,602.80 | -20.4% | +15.6% | +28.9% | |
| Jan 2, 2025 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 300,000 | $25.14 | $7,542,000.00 | -96.1% | -27.4% | -10.8% | |
| Jan 2, 2025 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 5,304 | $13.91 | $73,802.05 | -0.9% | +3.1% | +42.1% | |
| Jan 2, 2025 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $230.99 | $461,980.00 | -2.5% | -2.4% | +7.1% | |
| Jan 2, 2025 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 12,236 | $3.60 | $44,012.89 | -0.2% | -37.2% | +108.9% | |
| Jan 2, 2025 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 75 | $230.99 | $17,324.25 | -0.8% | -2.4% | +7.1% | |
| Jan 2, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 4,000 | $3.96 | $15,827.60 | -1.0% | -25.6% | -52.7% | |
| Jan 2, 2025 | ICUI Icu Medical Inc/de | Jain Vivek83 | Chairman And CEO | Sell | 1,373 | $155.48 | $213,474.04 | -1.3% | -11.1% | -12.3% | |
| Jan 2, 2025 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 3,670 | $13.90 | $51,014.14 | -0.8% | +3.1% | +42.1% | |
| Dec 31, 2024 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 3,644,315 | $1.37 | $5,000,000.18 | -3.5% | - | - | |
| Dec 31, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 1,680 | $3.29 | $5,535.60 | -0.1% | -26.9% | +21.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.